Description
A potent, orally bioavailable inhibitor of PORCN (IC50s = 18.1 and 70 nM for mouse and Xenopus PORCN, respectively); inhibits β-catenin reporter activity (IC50 = 2.9 nM) and reduces the interaction of Wnt with its carrier protein WLS via decreased Wnt palmitoleation in STF3A cells; inhibits PA-1 teratocarcinoma colony formation in soft agar (IC50 = 35 nM); reduces tumor growth in a dose-dependent manner in mice carrying a mouse mammary tumor virus LTR-Wnt1 transgene and in A-1 and NCCIT teratocarcinoma mouse xenograft models (1-10 mg/kg); reduces growth and induces differentiation in colon adenocarcinoma mouse xenograft models that contain RSPO translocations,
Formal name: 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-N-(6-phenyl-3-pyridazinyl)-7H-purine-7-acetamide
Synonyms: ETC-1922159
Molecular weight: 391.4
CAS: 1638250-96-0
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cancer|Cell Signaling|Wnt Signaling||Research Area|Cell Biology|Cell Signaling|Wnt Signaling